INTRODUCTION
Portal hypertensive gastropathy (PHG) is a common finding in patients with cirrhosis and portal hypertension [1] and it is endoscopically characterized by a mosaic-like or snake skin pattern of the gastric mucosa, mainly in the body and fundus of the stomach and more rarely in the gastric antrum. These gastric mucosal lesions represent another frequent cause of upper gastrointestinal bleeding, even though esophagogastric varices remain the major source of bleeding in patients with portal hypertension [2] . PHG observed during endoscopy in patients with cirrhosis are very common, occurring in between 7% and 98% of cases according to different series [3] .
Vascular endothelial growth factor (VEGF) is a secreted, 46 kDa dimeric protein, active as direct and specific mitogen for vascular endothelial cells thus a well-known mediator of angiogenesis in physiological and pathological conditions [4] . High levels of VEGF in mesentery suggested its contribution in portal hypertension secondary to liver cirrhosis. 5 High serum VEGF in late stage may reflect its prognostic value in liver cirrhosis [5] . VEGF participates in regulation of angiogenesis in gastric wall in portal hypertension [6] . Very few studies have been recently published about this issue. So, the aim of this study was to evaluate the serum concentration of VEGF and gastric mucosal expression of VEGF and their possible association with PHG in patients with cirrhosis.
PATIENTS AND METHODS

Patients :
The current study was carried out on 68 patients with liver cirrhosis divided into two groups according to presence or absence of PHG attended or admitted to Hepatology, Gastroenterology and Infectious Diseases Department, Benha University Hospital, within the period between October 2014 and March2015, after approval by the scientific committee of Benha Faculty of Medicine. Another twenty-one persons served as control group.
Patients with cirrhosis were diagnosed by clinical manifestations, laboratory investigations and ultrasonography. Patients were classified according to presence or absence of portal hypertensive gastropathy which was diagnosed by upper gastrointestinal endoscopy.
Patients with congestive heart failure, renal failure, lung disease, malignancy, hepatic encephalopathy, gastrointestinal bleeding was excluded from this work at the time of study .
Methods :
All patients were subjected to full history taking thorough clinical examination and routine laboratory tests including liver biochemical profile as serum bilirubin (total, direct), serum albumin, prothrombin time, international normalized ratio and serum creatinine, viral markers: HCVAb (Hepatitis C virus antibody) and HBsAg(Hepatitis B virus surface antigen).Each patient was assigned a score and a grade reflecting the severity of liver affection according to:  The numerical system of Child Turcotte Pugh (CTP) The grading (I-IV) classification:  grades I and II were reclassified as small and  grades III and IV were reclassified as large for this study.
PHG were reported according to Modified grading system proposed by the Baveno III meeting (Baveno, Italy (2000) on portal hypertension [13] :  PHG is mild when a pink mosaic-like mucosal pattern with no red signs or black-brown spots is present.  PHG is severe when the mosaic-like mucosal pattern is red and superimposed by any red sign (red point lesions and/or cherry-red spots) or black-brown spots.
Gastric mucosal biopsies were taken for studying the expression of VEGF.
Statistical Analysis :
Statistical package (SPSS, version 10.0) was used for data management. Descriptive statistics was presented as mean±standard deviations for continuous variables, number and percentage for categorical variables (frequency distribution). Unpaired Student t-test (two sided) was used to test the significance of difference between the mean value of studied groups and chi -square test was used for comparison of categorical variables. Pearson correlation test was used to identify the correlation between VEGF and different clinicopathological variables. The significance level was set at p<0.05.
RESULTS
Characteristics of the studied patients :
Sixty eight patients with liver cirrhosis were included in this study. The cases were divided into two groups according to presence or absence of PHG, cases with PHG were fifty seven while the other eleven cases had no PHG. The mean age was 53.5±9.1 in patients with PHG compared to 55.9±10.6 in patients without PHG. There was no statistically significant difference between groups as regards to the age and gender but PHG tends to be more common in males than females (males were 35 cases and females were 22 cases).
HCV infection was found in 98.2% of patients. Most of patients presented at Child B grade, and had a higher MELD and uMELD scores. By ultrasonography; spleen size and Portal vein diameter were higher in cirrhotics with PHG than in cirrhotic without PHG cases. Otherwise, other ultasonographic parameters did not distinguish between the two groups ( Table 1) .
Regarding endoscopy, fifty seven cases had endoscopically based portal hypertensive gastropathy (83.8%) and eleven had no portal hypertensive gastropathy (16.2%). large varices were detected in (61.4%) of patients with PHG and small varices in (31.6 %) of patients ( Table 2) .
Serum VEGF in the studied groups :
Concerning serum VEGF value, it was significantly increased in cirrhotic patients with PHG as it ranges between (34-234.1) pg/ml with mean (65.3) pg/ml and also in cirrhotic patients without PHG as it ranges between (38.8-99.5) pg/ml with mean (62.7) pg/ml compared to control group as it ranges between (24.4-37.5) pg/ml with mean (28.3) pg/ml , but there was no statistically significant difference between cirrhotic patients with PHG and cirrhotic patients without PHG (Table 3) .
Expression of VEGF in gastric mucosa in studied groups : VEGF expression in gastric mucosa was highly significantly expressed in patients with liver cirrhosis with PHG than cirrhotic patients without PHG and control group (Table 4 and Figure 1 ,2).
VEGF and severity of liver disease :
There was no significant correlation between VEGF and severity of liver disease (Child, MELD and uMELD), varices grade, number of varices or PHG grade (Table 5) . PHG is clinically important because it may cause acute (and even) massive or insidious, blood loss. The diagnosis of PHG is (only) made endoscopically; which is often characterized by an abnormality of the gastric mucosa described as a mosaic-like pattern resembling 'snake-skin', with or without red spots [14] .
In the present study, PHG was observed in (83.8%) of patients, PHG was mild in (45.6%) of patients and severe in (54.4%) of patients, these results were near to the results of Kim et al. who observed PHG in (90%) of patients, PHG was mild in (25.4%) and severe in (64.7%) of patients [15] .
In this study, endoscopy revealed that PHG cases were associated with varices in (93%) of patients, (35) of them (61.4%) were with large varices and (18) of them (31.6%) of patients were with small varices; these results were in agreement with the results of Kim et al. who documented that PHG was associated with esophageal varices grade and the prevalence of PHG was higher in patients with large esophageal varices than in those with small sized varices [15] . This may results from a more severe portal hypertension in patients with both severe PHG and large esophageal varices. Moreover, in our study, endoscopy revealed that there was no significant difference between the two groups as regard to presence of gastric varices, these results agreed with the results of Kim et al. who stated that there was no correlation between gastric varices and PHG [15] .
Concerning VEGF serum values, our results showed that it was significantly increased in cirrhotic patients with PHG as it ranges between (34-234.1) pg/ml with mean (65.3) pg/ml and also in cirrhotic patients without PHG as it ranges between (38.8-99.5) pg/ml with mean (62.7) pg/ml compared to control group which ranges between ( 24.4-37.5 ) pg/ml with mean ( 28.3 )pg/ml, these results agreed with the results of Jaroszewicz et al. who observed also that VEGF value was significantly increased in liver cirrhosis with mean (153.1) pg/ml compared to healthy individuals (46. Expression of VEGF in gastric mucosa was highly significant in patients with liver cirrhosis without PHG (6.06 folds to control) and cirrhotic patients with PHG (31.12 folds to control) than control group, these results may be explained by Abdelmoaty et al who stated that VEGF might be involved in cirrhosis associated angiogenesis [5] .
The previous results agreed with the results of Pan et al. who showed a significantly elevated expression of VEGF in the gastric walls during the development of portal hypertension, the expression was mainly located in the basal layer of the gastric mucosa, suggesting that VEGF plays a certain role in the vascular changes of the gastric wall in portal hypertensive gastropathy [6] . These results agreed also with the results of Colle et al. who observed in patients and in animal models that there is an increased expression of VEGF in portal hypertensive gastric mucosa and can be involved in the development of portal hypertensive gastropathy [19] . Previous studies found in vivo increased angiogenesis in the mesenteric microvasculature of an experimental model of portal hypertension rats with cirrhosis, also showed increased expression of VEGF in the mesentery of these rats, which was significantly higher compared with the control groups [5]. Gjeorgjievski and Cappel proposed that gastric mucosal hypoxia and elevation of VEGF might accelerate mucosal angiogenesis and increase blood flow [20] .
Concerning the VEGF and severity of liver disease assessed by Child-Pugh score, MELD score and uMELD score, our results showed that there is no significant correlation between VEGF and these scores which was in agreement with Assy et al. who documented that circulating VEGF level in patients with liver cirrhosis could not serve as an indicator of the progression of chronic liver disease but rather, they may reflect increased portal hypertension or decreased hepatic regenerative activity or the combination of both [21] .
Concerning the VEGF and varices grade, our results showed that there is no significant correlation between them, which is similar to the results of Makhlouf et al. [22] .
CONCLUSION
In conclusion, the serum VEGF increase in patients with liver cirrhosis compared to healthy control. According to the expression VEGF in gastric mucosa, it was highly significant in patients with PHG than patients without PHG and control group. The serum VEGF didn't increase in patients with advanced stages of liver cirrhosis, which is reflected by Child-Pugh score, MELD score and uMELD score or with PHG grade as well.
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